secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K/A
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001193125-21-288697
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lyell Immunopharma corrects Executive Chairman Klausner's resignation effective date to Oct 1, 2021
--------------------------------------------------------------------------------

- Original 8-K had a typo; resignation date corrected to October 1, 2021.
- Dr. Richard Klausner resigns as Executive Chairman and employee, effective October 1, 2021.
- No other changes made to the original disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312521288697/0001193125-21-288697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312521288697/d239915d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-288697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer